BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31865591)

  • 1. The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.
    Bolf EL; Gillis NE; Barnum MS; Beaudet CM; Yu GY; Tomczak JA; Stein JL; Lian JB; Stein GS; Carr FE
    Horm Cancer; 2020 Feb; 11(1):34-41. PubMed ID: 31865591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
    Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
    Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling.
    Gillis NE; Taber TH; Bolf EL; Beaudet CM; Tomczak JA; White JH; Stein JL; Stein GS; Lian JB; Frietze S; Carr FE
    Endocrinology; 2018 Jun; 159(6):2484-2494. PubMed ID: 29750276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting thyroid hormone receptor beta in triple-negative breast cancer.
    Gu G; Gelsomino L; Covington KR; Beyer AR; Wang J; Rechoum Y; Huffman K; Carstens R; Andò S; Fuqua SA
    Breast Cancer Res Treat; 2015 Apr; 150(3):535-45. PubMed ID: 25820519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.
    Bolf EL; Gillis NE; Davidson CD; Cozzens LM; Kogut S; Tomczak JA; Frietze S; Carr FE
    Mol Carcinog; 2021 Dec; 60(12):874-885. PubMed ID: 34534367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.
    Choe M; Brusgard JL; Chumsri S; Bhandary L; Zhao XF; Lu S; Goloubeva OG; Polster BM; Fiskum GM; Girnun GD; Kim MS; Passaniti A
    J Cell Biochem; 2015 Oct; 116(10):2210-26. PubMed ID: 25808624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
    Zhang X; Jeyakumar M; Bagchi MK
    J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic Thyroid Cancer.
    Bolf EL; Gillis NE; Davidson CD; Rodriguez PD; Cozzens L; Tomczak JA; Frietze S; Carr FE
    Mol Cancer Res; 2020 Oct; 18(10):1443-1452. PubMed ID: 32554601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.
    Heublein S; Mayr D; Meindl A; Angele M; Gallwas J; Jeschke U; Ditsch N
    PLoS One; 2015; 10(6):e0127072. PubMed ID: 26029931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid Hormone Receptor Beta as Tumor Suppressor: Untapped Potential in Treatment and Diagnostics in Solid Tumors.
    Davidson CD; Gillis NE; Carr FE
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors.
    Joseph B; Ji M; Liu D; Hou P; Xing M
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4766-70. PubMed ID: 17911173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression.
    Guigon CJ; Kim DW; Zhu X; Zhao L; Cheng SY
    Endocrinology; 2010 Nov; 151(11):5528-36. PubMed ID: 20844001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland.
    McDonald L; Ferrari N; Terry A; Bell M; Mohammed ZM; Orange C; Jenkins A; Muller WJ; Gusterson BA; Neil JC; Edwards J; Morris JS; Cameron ER; Blyth K
    Dis Model Mech; 2014 May; 7(5):525-34. PubMed ID: 24626992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
    Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone receptor-specific interactions with steroid receptor coactivator-1 in the pituitary.
    Sadow PM; Koo E; Chassande O; Gauthier K; Samarut J; Xu J; O'Malley BW; Seo H; Murata Y; Weiss RE
    Mol Endocrinol; 2003 May; 17(5):882-94. PubMed ID: 12576486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRβ Agonism Induces Tumor Suppression and Enhances Drug Efficacy in Anaplastic Thyroid Cancer in Female Mice.
    Gillis NE; Cozzens LM; Wilson ER; Smith NM; Tomczak JA; Bolf EL; Carr FE
    Endocrinology; 2023 Aug; 164(10):. PubMed ID: 37702560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN.
    Sancisi V; Manzotti G; Gugnoni M; Rossi T; Gandolfi G; Gobbi G; Torricelli F; Catellani F; Faria do Valle I; Remondini D; Castellani G; Ragazzi M; Piana S; Ciarrocchi A
    Nucleic Acids Res; 2017 Nov; 45(19):11249-11267. PubMed ID: 28981843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.